Focus topics

Bangladesh produces Sinopharm vaccine

Sinopharm’s Chinese Covid vaccine will soon begin production in Bangladesh. As the Chinese news agency Xinhua reports, a declaration to this effect was already signed in Beijing and Dhaka on Monday during an online conference. According to the statement, pharmaceutical company Incepta will manufacture the Chinese vaccine in Bangladesh’s capital. According to the plan, a capacity of five million doses per month is targeted. Production is to start in three months.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Xi arrives in Hong Kong
    International reputation suffers
    VW CEO: partners inform us about human rights
    Ifo: Reduce raw material dependence on China